SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Hessman Eva 1961)
 

Sökning: WFRF:(Hessman Eva 1961) > Inflammatory cardio...

Inflammatory cardiomyopathies: short- and long-term outcomes after heart transplantation-a protocol for a systematic review and meta-analysis.

Bobbio, Emanuele (författare)
Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine
Lingbrant, Marie (författare)
Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine
Nwaru, Bright I, 1978 (författare)
Gothenburg University,Göteborgs universitet,Krefting Research Centre
visa fler...
Hessman, Eva, 1961 (författare)
Gothenburg University,Göteborgs universitet,Göteborgs universitetsbibliotek, Biomedicinska biblioteken,Gothenburg University Library, Biomedical Libraries
Lehtonen, Jukka (författare)
Karason, Kristjan, 1962 (författare)
Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine
Bollano, Entela, 1970 (författare)
Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine
visa färre...
 (creator_code:org_t)
2020-01-14
2020
Engelska.
Ingår i: Heart failure reviews. - : Springer Science and Business Media LLC. - 1573-7322 .- 1382-4147. ; 25:3, s. 481-485
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Heart transplantation (HTx) for patients with "giant cell myocarditis" (GCM) or "cardiac sarcoidosis" (CS) is still controversial. However, no single center has accumulated enough experience to investigate post-HTx outcome. The primary aim of this systematic review is to identify, appraise, and synthesize existing literature investigating whether patients who have undergone HTx because of GCM or CS have worse outcomes as compared with patients transplanted because of other etiologies. A systematic and comprehensive search will be performed using PubMed, Scopus, Web of Science, EMBASE, and Google Scholar, for studies published up to December 2019. Observational and interventional population-based studies will be eligible for inclusion. The quality of observational studies will be assessed using the Newcastle-Ottawa scale, while the interventional studies will be assessed using the Cochrane Effective Practice Organization of Care tool. The collected evidence will be narratively synthesized; in addition, we will perform a meta-analysis to pool estimates from studies considered to be homogenous. Reporting of the systematic review and meta-analysis will be in accordance with the Meta-analysis of Observational Studies in Epidemiology Preferred Reporting Items for Systematic reviews and Meta-Analysis guidelines. To our knowledge, this will be the first synthesis of outcomes, including survival, acute cellular rejection, and disease recurrence, in patients with either GCM or CS treated with HTx. Reviewing the suitability of HTx in this population and highlighting areas for further research will benefit both patients and healthcare providers. Trial registration: CRD42019140574.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Hälsovetenskap (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Health Sciences (hsv//eng)

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy